| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.1 |